check_circleStudy Completed

Cystic Fibrosis

Bayer Identifier:

Trial_1123

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Pilot study testing nifedipine in patients with cystic fibrosis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

13 - 19 Years
  • -

  • -

Trial summary

Enrollment Goal
6
Trial Dates
September 1984 - March 1985
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Adalat CC (Nifedipine, BAYA1040)
Accepts Healthy Volunteer
N/A

Trial design

A single-centre, randomised, double-blind, placebo-controlled pilot study of cross-over design testing nifedipine in patients with cystic fibrosis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.